Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Haoxuan Ying
Observed names:
Ying Haoxuan,
Ying, Haoxuan
Institutions:
University of Maryland, Baltimore,
Zhujiang Hospital,
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,
Southern Medical University
Observed institutions:
University of Maryland, Baltimore,
Zhujiang Hospital,
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,
Southern Medical University
ORCID:
0000-0002-0957-9827
Observed ORCID:
0000-0002-0957-9827
OpenAlex ID:
A5005546204
The microbiome in cancer
2025
·
Anqi Lin
, Minying Xiong
, et al.
·
iMeta
·
107
PDF
MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer
2022
·
Ruibin Yi
, Shuo Hong
, et al.
·
Frontiers in Cell and Developmental Biology
·
42
Multi‑omics identification of a signature based on malignant cell-associated ligand–receptor genes for lung adenocarcinoma
2024
·
Shengshan Xu
, Xiguang Chen
, et al.
·
BMC Cancer
·
40
Targeting PFKFB4 Biomimetic Codelivery System Synergistically Enhances Ferroptosis to Suppress Small Cell Lung Cancer and Augments the Efficacy of Anti‐PD‐L1 Immunotherapy
2025
·
Xiang Liu
, Jingjun He
, et al.
·
Advanced Science
·
19
PDF
Activation of the chemokine receptor 3 pathway leads to a better response to immune checkpoint inhibitors in patients with metastatic urothelial carcinoma
2022
·
Wenqin Feng
, Anqi Lin
, et al.
·
Cancer Cell International
·
10
PDF
Homologous recombination deficiency ( HRD ) is associated with better prognosis and possibly causes a non‐inflamed tumour microenvironment in nasopharyngeal carcinoma
2024
·
Xinyi Zhou
, Haoxuan Ying
, et al.
·
The Journal of Pathology Clinical Research
·
5
Association Between FSIP2 Mutation and an Improved Efficacy of Immune Checkpoint Inhibitors in Patients With Skin Cutaneous Melanoma
2021
·
Haoxuan Ying
, Anqi Lin
, et al.
·
Frontiers in Molecular Biosciences
·
5
PDF
HDAC Inhibition Unlocks Tumor Plasticity and Enhances Immunotherapy Response in Myc-Driven Small Cell Lung Cancer
2026
·
Azam Ghafoor
, Linying Zhu
, et al.
·
Molecular Cancer Therapeutics
·
4
Integrative machine learning approach for forecasting lung cancer chemosensitivity: From algorithm to cell line validation
2025
·
Jinghong Chen
, Yonglin Yi
, et al.
·
Computational and Structural Biotechnology Journal
·
4
PDF
TGM2-TUFM promotes acquired resistance to EGFR-TKIs in EGFR-mutated NSCLC through p62-mediated lipophagy
2026
·
Jie Shen
, Lanying Gou
, et al.
·
Respiratory Research
·
1
KDM4B/DHX9 promotes chemoresistance in small-cell lung cancer through the MYCN-driven signaling pathway
2026
·
Qiong Lyu
, Huiying Liu
, et al.
·
Oncogene
·
1
PDF
THER: Integrative Web Tool for Tumour Hypoxia Exploration and Research
2025
·
Yasi Zhang
, Huiying Liu
, et al.
·
Cell Proliferation
·
1
PDF
SPP1+ tumor-associated macrophages induce radioresistance of nasopharyngeal carcinoma through crosstalk with the tumor microenvironment
2024
·
Wenda Zhang
, Lili Lin
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
Large language models reveal a systematic preference in clinical immunotherapy guidelines: a multi-model comparative analysis
2026
·
Zhenyu Chen
, Anqi Lin
, et al.
·
Scientific Reports
PDF
HGD-derived N-formylkynurenine promotes small cell lung cancer chemoresistance by activating ATL2-mediated endoplasmic reticulum remodelling.
2026
·
Weitao Shen
, Ruibin Yi
, et al.
·
Research Square
Clinical and molecular characteristics, transcriptome, and drug efficacy of ERBB2 tyrosine kinase and non-tyrosine kinase mutations in non-small cell lung cancer
2023
·
xiaopan zheng
, Haitao Li
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
25
Citation count:
240
H-index:
5
I10-index:
5
Year
Topic
Type